Julian Harrison
Stock Analyst at BTIG
(3.32)
# 1,017
Out of 5,008 analysts
52
Total ratings
51.11%
Success rate
3.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Julian Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLYM Climb Bio | Maintains: Buy | $7 → $8 | $1.81 | +341.99% | 2 | Sep 30, 2025 | |
| MLTX MoonLake Immunotherapeutics | Downgrades: Neutral | $85 | $8.66 | +881.52% | 2 | Sep 29, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $56 | $20.33 | +175.45% | 2 | Sep 29, 2025 | |
| AVTX Avalo Therapeutics | Reiterates: Buy | $40 | $14.00 | +185.71% | 2 | Sep 29, 2025 | |
| NKTR Nektar Therapeutics | Reiterates: Buy | $100 | $59.93 | +66.86% | 1 | Sep 19, 2025 | |
| RZLT Rezolute | Reiterates: Buy | $17 | $8.81 | +92.96% | 3 | Sep 18, 2025 | |
| SYRE Spyre Therapeutics | Reiterates: Buy | $70 | $16.67 | +319.92% | 3 | Sep 16, 2025 | |
| MAZE Maze Therapeutics | Maintains: Buy | $30 → $37 | $27.52 | +34.45% | 3 | Sep 12, 2025 | |
| CGEM Cullinan Therapeutics | Reiterates: Buy | $32 | $5.84 | +447.95% | 1 | Sep 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Reiterates: Buy | $112 | $86.67 | +29.23% | 2 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $25 | $14.59 | +71.35% | 2 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $10.00 | +320.00% | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $15.62 | - | 3 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $30.25 | - | 2 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $9 | $1.09 | +725.69% | 5 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8 | $1.90 | +321.05% | 4 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $0.36 | +2,120.37% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $56 → $61 | $20.83 | +192.85% | 3 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $25 | $22.86 | +9.36% | 3 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $51 | $64.14 | -20.49% | 2 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $43 | $39.82 | +7.99% | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $4 | $2.97 | +34.68% | 1 | Nov 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $150 | $1.90 | +7,786.44% | 1 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $453.28 | - | 2 | Feb 11, 2022 |
Climb Bio
Sep 30, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $1.81
Upside: +341.99%
MoonLake Immunotherapeutics
Sep 29, 2025
Downgrades: Neutral
Price Target: $85
Current: $8.66
Upside: +881.52%
Oruka Therapeutics
Sep 29, 2025
Reiterates: Buy
Price Target: $56
Current: $20.33
Upside: +175.45%
Avalo Therapeutics
Sep 29, 2025
Reiterates: Buy
Price Target: $40
Current: $14.00
Upside: +185.71%
Nektar Therapeutics
Sep 19, 2025
Reiterates: Buy
Price Target: $100
Current: $59.93
Upside: +66.86%
Rezolute
Sep 18, 2025
Reiterates: Buy
Price Target: $17
Current: $8.81
Upside: +92.96%
Spyre Therapeutics
Sep 16, 2025
Reiterates: Buy
Price Target: $70
Current: $16.67
Upside: +319.92%
Maze Therapeutics
Sep 12, 2025
Maintains: Buy
Price Target: $30 → $37
Current: $27.52
Upside: +34.45%
Cullinan Therapeutics
Sep 10, 2025
Reiterates: Buy
Price Target: $32
Current: $5.84
Upside: +447.95%
ABIVAX Société Anonyme
Sep 9, 2025
Reiterates: Buy
Price Target: $112
Current: $86.67
Upside: +29.23%
Jun 27, 2025
Maintains: Buy
Price Target: $24 → $25
Current: $14.59
Upside: +71.35%
Dec 19, 2024
Initiates: Buy
Price Target: $42
Current: $10.00
Upside: +320.00%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $15.62
Upside: -
Dec 2, 2024
Downgrades: Neutral
Price Target: n/a
Current: $30.25
Upside: -
Nov 29, 2024
Maintains: Buy
Price Target: $50 → $9
Current: $1.09
Upside: +725.69%
Nov 19, 2024
Upgrades: Buy
Price Target: $8
Current: $1.90
Upside: +321.05%
Nov 18, 2024
Initiates: Buy
Price Target: $8
Current: $0.36
Upside: +2,120.37%
Sep 26, 2024
Maintains: Buy
Price Target: $56 → $61
Current: $20.83
Upside: +192.85%
Aug 20, 2024
Maintains: Buy
Price Target: $29 → $25
Current: $22.86
Upside: +9.36%
Jul 24, 2024
Maintains: Buy
Price Target: $41 → $51
Current: $64.14
Upside: -20.49%
Dec 20, 2023
Initiates: Buy
Price Target: $43
Current: $39.82
Upside: +7.99%
Nov 29, 2023
Assumes: Buy
Price Target: $4
Current: $2.97
Upside: +34.68%
Oct 11, 2023
Reinstates: Buy
Price Target: $150
Current: $1.90
Upside: +7,786.44%
Feb 11, 2022
Initiates: Neutral
Price Target: n/a
Current: $453.28
Upside: -